Metabolic characteristics of converters to ICA positivity in the diabetes prevention trial-type 1 (DPT-1)

被引：0
|
作者：
Sosenko, Jay M.
Wherrett, Diane
Rafkin-Mervis, Lisa
Palmer, Jerry P.
Skyler, Jay S.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A482 / A482
页数：1
相关论文
共 50 条
  • [41] Effects of oral insulin in relatives of patients with type 1 diabetes - The diabetes prevention trial-type 1
    DIABETES CARE, 2005, 28 (05) : 1068 - 1076
  • [42] Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1
    Sosenko, Jay M.
    Palmer, Jerry P.
    Rafkin-Mervis, Lisa
    Krischer, Jeffrey P.
    Cuthbertson, David
    Mahon, Jeffery
    Greenbaum, Carla J.
    Cowie, Catherine C.
    Skyler, Jay S.
    DIABETES CARE, 2009, 32 (09) : 1603 - 1607
  • [43] The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
    Sosenko, Jay M.
    Skyler, Jay S.
    Mahon, Jeffrey
    Krischer, Jeffrey P.
    Beam, Craig A.
    Boulware, David C.
    Greenbaum, Carla J.
    Rafkin, Lisa E.
    Cowie, Catherine
    Cuthbertson, David
    Palmer, Jerry P.
    DIABETES CARE, 2012, 35 (07) : 1552 - 1555
  • [44] HbA1c correlated with pasting and postprandial glucose levels in subjects in the diabetes prevention trial-1 (DPT-1)
    Kaufman, FR
    Cuthbertson, DD
    Krischer, JP
    DIABETES, 2001, 50 : A96 - A96
  • [45] Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
    Sosenko, Jay M.
    Palmer, Jerry P.
    Rafkin-Mervis, Lisa
    Krischer, Jeffrey P.
    Cuthbertson, David
    Matheson, Della
    Skyler, Jay S.
    DIABETES CARE, 2008, 31 (11) : 2188 - 2192
  • [46] No difference in insulin sensitivity between "silent" type 1 diabetes, diabetes prevention trial-type 1, and control subjects
    Prigeon, RL
    D'Alessio, DA
    Greenbaum, CJ
    DIABETES, 2000, 49 : A301 - A301
  • [47] Insulin sensitivity is not different between silent type 1 diabetes, DPT-1, and control subjects
    Greenbaum, CJ
    D'Alessio, DA
    Prigeon, RL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 75A - 75A
  • [48] Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes
    Sosenko, Jay M.
    Skyler, Jay S.
    Mahon, Jeffrey
    Krischer, Jeffrey P.
    Greenbaum, Carla J.
    Rafkin, Lisa E.
    Beam, Craig A.
    Boulware, David C.
    Matheson, Della
    Cuthbertson, David
    Herold, Kevan C.
    Eisenbarth, George
    Palmer, Jerry P.
    DIABETES CARE, 2014, 37 (04) : 979 - 984
  • [49] A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants
    Sosenko, Jay M.
    Mahon, Jeffrey
    Rafkin, Lisa
    Lachin, John M.
    Krause-Steinrauf, Heidi
    Krischer, Jeffrey P.
    Cuthbertson, David
    Palmer, Jerry P.
    Thompson, Clinton
    Greenbaum, Carla J.
    Skyler, Jay S.
    PEDIATRIC DIABETES, 2011, 12 (02) : 85 - 90
  • [50] The Development, Validation, and Utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)
    Sosenko, Jay M.
    Skyler, Jay S.
    Palmer, Jerry P.
    CURRENT DIABETES REPORTS, 2015, 15 (08)
12345